Northwest PK Solutions

Executive Summary

Northwest PK Solutions is a boutique pharmacokinetics consulting firm based in Seattle, Washington, founded in 2011 (incorporated 2013). The company specializes in designing, monitoring, and analyzing PK, PK/PD, toxicokinetics, and biodistribution studies for small molecules and protein-based therapeutics. Serving clients from preclinical research through early clinical trials and regulatory submissions, Northwest PK Solutions positions itself as a niche partner for biotech and pharmaceutical companies seeking expert guidance in drug development. Despite operating in a competitive landscape, its focus on personalized service and deep technical expertise allows it to differentiate from larger CROs, enabling flexible and high-quality support for complex PK challenges. As a private Phase 1 consultancy, Northwest PK Solutions lacks public financial disclosures, but its steady presence since 2011 suggests a loyal client base and recurring revenue. The firm is poised to benefit from the growing demand for specialized PK services as drug development becomes more complex. Key catalysts could include securing contracts with emerging biotech firms, expanding service offerings into new modalities like ADCs or gene therapies, or forming strategic partnerships with contract research organizations (CROs) to scale its reach. However, the company remains small, and its growth trajectory is tied to the success of its client projects and overall industry R&D spending.

Upcoming Catalysts (preview)

• Q3 2026New Contract Win with a Mid-Size Biotech70% success
• Q4 2026Expansion of Services into Gene Therapy PK Support50% success
• Q2 2027Partnership with a Top CRO for Subcontracted Work40% success